The Full Wiki

More info on WAY-317,538

WAY-317,538: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

Systematic (IUPAC) name
5-morpholin-4-yl-pentanoic acid (4-pyridin-3-yl-phenyl)-amide
ATC code  ?
Chemical data
Formula C20H25N3O2 
Mol. mass 339.430
SMILES eMolecules & PubChem
Therapeutic considerations
Pregnancy cat.  ?
Legal status Legal

WAY-317,538 (SEN-12333) is a drug which acts as a potent and selective full agonist for the α7 subtype of neural nicotinic acetylcholine receptors. It was not the most potent compound in the series, but was selected for further development on the basis of its high selectivity over related receptors, ease of synthesis, and good in vivo properties including high oral bioavailability and good brain penetration.[1] It has nootropic and neuroprotective effects in animal studies, and is being investigated as a potential treatment for neurodegenerative conditions including Alzheimer's disease and schizophrenia.[2]


  1. ^ Haydar, S.; Ghiron, C.; Bettinetti, L.; Bothmann, H.; Comery, T.; Dunlop, J.; La Rosa, S.; Micco, I. et al. (2009). "SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist.". Bioorganic & medicinal chemistry 17 (14): 5247–5258. doi:10.1016/j.bmc.2009.05.040. PMID 19515567.  edit
  2. ^ Roncarati, R.; Scali, C.; Comery, T.; Grauer, S.; Aschmi, S.; Bothmann, H.; Jow, B.; Kowal, D. et al. (2009). "Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders". The Journal of pharmacology and experimental therapeutics 329 (2): 459–468. doi:10.1124/jpet.108.150094. PMID 19223665.  edit


Got something to say? Make a comment.
Your name
Your email address